Company · CIK 1292087

# Lotus Pharmaceuticals, Inc.

| CIK | [1292087](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001292087) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | NV |
| Business address | China |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2008-04-14 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-150879 | Registered company Effective | 2008-05-13 | 2008-07-25 | 4 |

## Filings

 7

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2008-07-25 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1292087/999999999508002311/9999999995-08-002311-index.htm) Declared effective | 333-150879 | 9999999995-08-002311 |
| 2008-07-18 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1292087/000116169708000793/0001161697-08-000793-index.htm) Amendment | 333-150879 | 0001161697-08-000793 |
| 2008-06-20 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1292087/000116169708000711/0001161697-08-000711-index.htm) Amendment | 333-150879 | 0001161697-08-000711 |
| 2008-06-17 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1292087/999999999508001923/9999999995-08-001923-index.htm) Declared effective | 333-142355 | 9999999995-08-001923 |
| 2008-05-13 | [S-1](https://www.sec.gov/Archives/edgar/data/1292087/000116169708000533/0001161697-08-000533-index.htm) Registration filed | 333-150879 | 0001161697-08-000533 |
| 2007-05-04 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1292087/999999999507001779/9999999995-07-001779-index.htm) Declared effective | 333-142355 | 9999999995-07-001779 |
| 2005-07-25 | [RW](https://www.sec.gov/Archives/edgar/data/1292087/000112178105000182/0001121781-05-000182-index.htm) Withdrawn | 001-32581 | 0001121781-05-000182 |

[All filings of this company](https://equitycapital.markets/filings?cik=1292087) · [CSV](https://equitycapital.markets/filings.csv?cik=1292087)

---
Source page: https://equitycapital.markets/company/1292087 · Data: U.S. SEC EDGAR · CC BY 4.0